Associate Director, Clinical Scientist, Genetics Medicine
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking an Associate Director, Clinical Sciences to join our Clinical Development Unit, supporting our clinical programs in a matrixed, cross-functional environment. In this role, you will lead the design, execution, and scientific interpretation of clinical studies across early and late phase development, ensuring the integrity of study data and the safety of patients. You will collaborate closely with Medical Directors, regulatory, and other cross-functional partners to move promising candidates forward.
Job description
When & where
- Location: Tarrytown, NY, Warren, NJ, Cambridge, MA
- Work model/flexibility: Primarily on-site with hybrid flexibility
Discover your role
- Lead or support clinical science strategy for a program, serving as lead Clinical Scientist or delegate to the Therapeutic Area Lead
- Partner with Medical Directors to design and deliver clinical studies grounded in disease biology and current literature
- Develop the Expanded Synopsis and author or review the clinical sections of protocols, amendments, and study reports
- Prepare medical monitoring plans, SAPs, and informed consents, and resolve cross-functional comments with minimal guidance
- Perform clinical data review and safety monitoring to protect patient safety and data integrity
- Present at program team meetings, advisory boards, steering committees, DMCs, and investigator meetings
- Identify risks, design mitigation strategies, and drive process improvements across studies
- Influence across functions and mentor junior colleagues with confidence, creativity, and professional diplomacy
This role requires
- Bachelor’s degree and 10+ years of pharmaceutical clinical drug development experience (other levels considered depending on experience)
- Proficient knowledge of the drug development process, ICH/GCP guidelines, study design, and clinical research methodology
- Demonstrated leadership in conducting global clinical trials and executing clinical programs
- Strong cross-functional leadership, interpersonal, and problem-solving skills in a matrix environment
- Solid medical writing skills
- Preferred: Advanced degree in life science or healthcare (PhD, MD, PharmD, or MSc)
- Preferred: Proven track record of clinical trial process improvements and experience across early and late phase development
Requirements
- Bachelor’s degree
- 10+ years of pharmaceutical clinical drug development experience
- Proficient knowledge of the drug development process
- Proficient knowledge of ICH/GCP guidelines
- Proficient knowledge of study design
- Proficient knowledge of clinical research methodology
- Demonstrated leadership in conducting global clinical trials
- Demonstrated leadership in executing clinical programs
- Strong cross-functional leadership skills
- Strong interpersonal skills
- Strong problem-solving skills
- Solid medical writing skills
- Preferred: Advanced degree in life science or healthcare (PhD, MD, PharmD, or MSc)
- Preferred: Proven track record of clinical trial process improvements
- Preferred: Experience across early and late phase development
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.